Logo image of PRSO

PERASO INC (PRSO) Stock Fundamental Analysis

NASDAQ:PRSO - Nasdaq - US71360T2006 - Common Stock - Currency: USD

0.97  -0.04 (-3.96%)

After market: 0.9653 0 (-0.48%)

Fundamental Rating

3

PRSO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. PRSO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PRSO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

PRSO had negative earnings in the past year.
PRSO had a negative operating cash flow in the past year.
In the past 5 years PRSO always reported negative net income.
In the past 5 years PRSO always reported negative operating cash flow.
PRSO Yearly Net Income VS EBIT VS OCF VS FCFPRSO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

PRSO has a worse Return On Assets (-136.32%) than 96.36% of its industry peers.
Looking at the Return On Equity, with a value of -255.30%, PRSO is doing worse than 90.91% of the companies in the same industry.
Industry RankSector Rank
ROA -136.32%
ROE -255.3%
ROIC N/A
ROA(3y)-149.9%
ROA(5y)-104.55%
ROE(3y)-311.07%
ROE(5y)-220.29%
ROIC(3y)N/A
ROIC(5y)N/A
PRSO Yearly ROA, ROE, ROICPRSO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

With a decent Gross Margin value of 57.00%, PRSO is doing good in the industry, outperforming 78.18% of the companies in the same industry.
In the last couple of years the Gross Margin of PRSO has declined.
The Profit Margin and Operating Margin are not available for PRSO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.81%
GM growth 5Y-3.27%
PRSO Yearly Profit, Operating, Gross MarginsPRSO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

5

2. Health

2.1 Basic Checks

PRSO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PRSO has more shares outstanding
Compared to 5 years ago, PRSO has more shares outstanding
PRSO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PRSO Yearly Shares OutstandingPRSO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
PRSO Yearly Total Debt VS Total AssetsPRSO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

PRSO has an Altman-Z score of -36.69. This is a bad value and indicates that PRSO is not financially healthy and even has some risk of bankruptcy.
PRSO has a worse Altman-Z score (-36.69) than 86.36% of its industry peers.
There is no outstanding debt for PRSO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -36.69
ROIC/WACCN/A
WACC11.59%
PRSO Yearly LT Debt VS Equity VS FCFPRSO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 2.01 indicates that PRSO has no problem at all paying its short term obligations.
PRSO has a worse Current ratio (2.01) than 75.45% of its industry peers.
PRSO has a Quick Ratio of 1.41. This is a normal value and indicates that PRSO is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of PRSO (1.41) is worse than 75.45% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 1.41
PRSO Yearly Current Assets VS Current LiabilitesPRSO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 90.92% over the past year.
Looking at the last year, PRSO shows a very strong growth in Revenue. The Revenue has grown by 35.49%.
Measured over the past years, PRSO shows a small growth in Revenue. The Revenue has been growing by 7.64% on average per year.
EPS 1Y (TTM)90.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.36%
Revenue 1Y (TTM)35.49%
Revenue growth 3Y36.91%
Revenue growth 5Y7.64%
Sales Q2Q%37.39%

3.2 Future

PRSO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.03% yearly.
Based on estimates for the next years, PRSO will show a small growth in Revenue. The Revenue will grow by 7.63% on average per year.
EPS Next Y48.77%
EPS Next 2Y34.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.61%
Revenue Next 2Y14.75%
Revenue Next 3Y7.63%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
PRSO Yearly Revenue VS EstimatesPRSO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
PRSO Yearly EPS VS EstimatesPRSO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 0 -1K -2K -3K -4K

1

4. Valuation

4.1 Price/Earnings Ratio

PRSO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PRSO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRSO Price Earnings VS Forward Price EarningsPRSO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRSO Per share dataPRSO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as PRSO's earnings are expected to grow with 34.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.03%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PRSO!.
Industry RankSector Rank
Dividend Yield N/A

PERASO INC

NASDAQ:PRSO (7/15/2025, 8:15:12 PM)

After market: 0.9653 0 (-0.48%)

0.97

-0.04 (-3.96%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-11 2025-08-11/amc
Inst Owners10.4%
Inst Owner Change0%
Ins Owners2.55%
Ins Owner Change1.58%
Market Cap4.88M
Analysts82.86
Price Target3.35 (245.36%)
Short Float %3.55%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.4%
Min EPS beat(2)37.83%
Max EPS beat(2)50.98%
EPS beat(4)2
Avg EPS beat(4)-22.35%
Min EPS beat(4)-136.37%
Max EPS beat(4)50.98%
EPS beat(8)4
Avg EPS beat(8)-17%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.87%
Min Revenue beat(2)-5.43%
Max Revenue beat(2)-0.31%
Revenue beat(4)0
Avg Revenue beat(4)-3.67%
Min Revenue beat(4)-6.79%
Max Revenue beat(4)-0.31%
Revenue beat(8)3
Avg Revenue beat(8)-1.19%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-3.41%
EPS NQ rev (3m)-5.81%
EPS NY rev (1m)5.6%
EPS NY rev (3m)-75.2%
Revenue NQ rev (1m)-4.74%
Revenue NQ rev (3m)-5.86%
Revenue NY rev (1m)-3.14%
Revenue NY rev (3m)-2.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB 1.36
EV/EBITDA N/A
EPS(TTM)-1.43
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS3.11
BVpS0.71
TBVpS0.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -136.32%
ROE -255.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57%
FCFM N/A
ROA(3y)-149.9%
ROA(5y)-104.55%
ROE(3y)-311.07%
ROE(5y)-220.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.81%
GM growth 5Y-3.27%
F-Score5
Asset Turnover2.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.01
Quick Ratio 1.41
Altman-Z -36.69
F-Score5
WACC11.59%
ROIC/WACCN/A
Cap/Depr(3y)11.82%
Cap/Depr(5y)21.25%
Cap/Sales(3y)2.49%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.36%
EPS Next Y48.77%
EPS Next 2Y34.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.49%
Revenue growth 3Y36.91%
Revenue growth 5Y7.64%
Sales Q2Q%37.39%
Revenue Next Year-2.61%
Revenue Next 2Y14.75%
Revenue Next 3Y7.63%
Revenue Next 5YN/A
EBIT growth 1Y64.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.39%
OCF growth 3YN/A
OCF growth 5YN/A